Cancer Research · 2008 · 484 citations · 31 references
Life SciencesMolecular BiologyOncologyApoptosisGene ExpressionMolecular OncologyColorectal CancerMicrorna BiologyMicrorna-mediated RegulationNoncoding Rna In CancerRna InterferenceTumor Suppressor GenesMicrorna Function In CancerMicrorna Gene RegulationMicrorna In ApoptosisMicrorna In CancerMicrorna Regulation In CancerMicrorna Regulation Of ApoptosisTumor Suppression MechanismsTumor Suppressor P53
microRNAs provide a novel layer of regulation for gene expression by interfering with the stability and/or translation of specific target mRNAs. Overall levels of microRNAs are frequently down-regulated in cancer cells, and reducing general microRNA processing increases cancerogenesis in transgenic models, suggesting that at least some microRNAs might act as effectors in tumor suppression. Accordingly, the tumor suppressor p53 up-regulates miR-34a, a microRNA that contributes to apoptosis and acute senescence. Here, we used array hybridization to find that p53 induces two additional, mutually related clusters of microRNAs, leading to the up-regulation of miR-192, miR-194, and miR-215. The same microRNAs were detected at high levels in normal colon tissue but were severely reduced in many colon cancer samples. On the other hand, miR-192 and its cousin miR-215 can each contribute to enhanced CDKN1A/p21 levels, colony suppression, cell cycle arrest, and cell detachment from a solid support. These effects were partially dependent on the presence of wild-type p53. Antagonizing endogenous miR-192 attenuated 5-fluorouracil-induced accumulation of p21. Hence, miR-192 and miR-215 can act as effectors as well as regulators of p53; they seem to suppress cancerogenesis through p21 accumulation and cell cycle arrest.
31
MicroRNA expression profiles classify human cancers
Jun Lü, Gad Getz, Eric A. Miska et al. · Nature · 2005 · 9.6K citations
Real-time quantification of microRNAs by stem-loop RT-PCR
C. Chen · Nucleic Acids Research · 2005 · 5K citations · Full text
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Lyubomir T. Vassilev, Binh Thanh Vu, Bradford Graves et al. · Science · 2004 · 4.7K citations
Medicine, Oncology, Pharmacology +15
Silencing of microRNAs in vivo with ‘antagomirs’
Jan Krützfeldt, Nikolaus Rajewsky, Ravi Braich et al. · Nature · 2005 · 4K citations
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Pablo Landgraf, Mirabela Rusu, Robert P. Sheridan et al. · Cell · 2007 · 3.7K citations · Full text